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Comparison of the primary structures of high% urokinase and tissue-type plasminogen activator reveals 
a high degree of structural homology between the two proteins, except that tissue activator contains a 43 
residue long amino-terminal region, which has no counterpart in urokinase. We show that his segment 
is homologous with the finger-domains responsible for the fibrin-affinity of fibronectin. Limited 
proteolysis of the amino-terminal region of plasminogen activator was found to lead to a loss of the fibrin- 
affinity of the enzyme. It is suggested that the finger-domains of fibronectin and tissue-types plasminogen 
activator have similar functions and that the finger-domains of the two proteins evolved from a common 
ancestral fibrin-binding domain. 
Tissue-type plasminogen activator Fibronectin 
1. INTRODUCTION 
Activation of plasminogen 
plasminogen activators is known _ _. 
by tissue-type 
to be greatly ac- 
celerated by the presence of fibrin [ 1,2]. The 
molecular basis of the stimulatory effect of fibrin 
is that both plasminogen [3,4] and plasminogen ac- 
tivator [5,6] are bound by the fibrin polymer and 
fibrin facilitates plasminogen activation by align- 
ing the enzyme with its substrate [2]. The 
physiological significance of this molecular 
mechanism is that it ensures that plasminogen ac- 
tivation takes place predominantly on fibrin sur- 
face and thus restricts plasmin action to fibrin [7]. 
Urokinase-type plasminogen activators lack this 
fibrin-specificity, since they are devoid of fibrin- 
affinity [5,6]. 
Recently the primary structures of human tissue- 
type plasminogen activator [8] and human high A& 
urokinase [9,10] have been determined, and the 
Abbreviations: t-PA, tissue-type plasminogen activator; 
SDS, sodium dodecyl sulfate 
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Protein evolution Fibrin-binding domain 
carboxy-terminal regions of the two proteins have 
been shown to be homologous with the protease 
parts of prothrombin, plasminogen, trypsin and 
other trypsin-like serine proteases. The non- 
protease part of tissue-type plasminogen activator 
was shown to contain two kringle structures that 
are homologous to the kringles of prothrombin 
[ 111, plasminogen [12], and urokinase [9]; the re- 
maining amino-terminal 91 amino acids of tissue- 
type plasminogen activator, however, were found 
to share little homology with kringles [8]. 
We here show that this region consists of a seg- 
ment homologous with the growth factor-domain 
present in various proteases and another segment 
that shows homology with the finger-domains of 
fibronectin. 
2. MATERIALS AND METHODS 
2. I. Limitedproteolysis of tissue-typeplasminogen 
activator by plasmin-Sepharose 4B 
Melanoma t-PA was isolated from the serum- 
free harvest fluid of the Bowes human melanoma 
cell line [6]. t-PA, 100 Ploug units in 1 ml of 0.05 
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M Tris-Ha, 0.35 M N&I, 0.0~~0 Tween~O tjm 
7.4) was digested with plasmin~Seph~ose 48 (0.5 
ml) for 15 min at 25°C. 
c&t 
melanoma t-PA (50 PIoug u~ts~rnl) or UK (10 
Ploug units/ml), plasminogen-free fibrinogen 
(1.25 mg/ml) and bovine thrombin (1 NIH 
unit/ml) were incubated at 25T in 0.05 M 
‘Iris-EICl, 0.15 M NaCf, 0.~2~s Twined, pH 
7.4, The clot formed was continuously removed 
and squeal by the aid of a glass-rod ying a 
period of 30 min. Activator species not adsorbed 
to fibrin were analyzed from the liquid remaining 
after removal of fibrin clot, Activator species ad- 
sorbed to fibrin were extracted from the clot by 
2% SDS. 
2.3. Defecfim ofpfasminogen a~tiva#or qwcies ott 
SDS-palyacryiamide slab gels containing co- 
po~~~@~~~ed ~~as~i~~g~n and gelatin 
P~minoge~ activators were detected on It 1% 
S~S-pol~c~I~ide sfab geIs ~nt~~~ 
co~l~e~~ed plas~~oge~ and gelatin EI 33. The 
method utilizes the fact that the zymogen and 
gelatin incorporated into the polyacrylamide 
matrix at the time of casting are retained uring 
sub~~~~t elec~ophoresis of ~A-s~pl~ and 
serve as sequential, in situ substrates for localiza- 
tion of PA-bands by negative staining, Pailure of 
proteolysis to occur in plasminogen-free control 
gels was used as the criterion of plasminogen ac- 
tivator activity; SDS was removed by immersion of
the slabs intu 2.5% Triton X-100 for 60 min with 
concomit~t restoration of activity* The gels were 
incubated in 0. I I)4 glycine-NaOH (pH 8.3) buffer 
for 180 min at 37’C and then stained with 
0. I % amide-black in methanokacetic acid:water 
(30: f0:60) and destained in methanol~acetic 
acid:water (30: 1MO). 
3. RESULTS AND DISCUSSION 
Here we show (fig-IA) that residues 44-B of 
pIasmino~en a~va~or display remarkabIe se- 
quence homology with human and Maine epider- 
ma1 growth factors [14,iJ] and the growth factor- 
like regions of protein C 1161, factor IX [17], fac- 
tor X [18] and urokinase 191; the degree of identity 
for residues 56-84 was found to be 26, 33, 36,43 
and 50% r~~ively. 
The ~~o~te~in~ 43 residue long segment of 
tissue-type plasminogen activator, however, has no 
counterpart in urokinase, raising the possibility 
that this region might be responsible for some of 
the properties dis~gulshi~ tissue-type 
p~s~uoge~ activatur from urokinase, corn- 
parison of tbe amino acid sequence of this segment 
witb the sequence of fibronectin 119] revealed that 
it is homologous with the finger-structures of
fibronectin (fig. 1B) that are known to be responsi- 
ble for the ~brin-~~i~it~ of fibronectin [20,2I]. 
When the sequences of the 9 fibronectin fingers are 
compared, one by one, with the ~no-terminal43 
residues of tissue-activator, the degree of identity 
for residues 6-43 is found to range from 20-27%, 
It is noteworthy that 6 of the 7 residues, conserved 
FX KNGIG 
Fxx 
c DRPBGSPO DLF 
lni?xx SYPGCP@SYDGY MNIESL 
hEa SDGECPLSHDGY IYIEAL 
Fig.IA* ~~rn~~~~ of residues 44-91 of t~ss~~t~~ asrn~~og~~ activator with ~~rr~s~~d~~ parts of s&w pro- 
teases. The sequence of hrxman t-PA, residtzes 44-91, was taken frum [g]; human ~~~~~~ ttrokirrase, residues 5-49 
from {9]; bo~hz factor X, residues 54-88 from fig]; bovine facttx Xx, residues 54-S from [I?]; bovine protein C, 
residues 52-96 from [16]; mu&e epidermal growth factor, residues 2-49 from [I!$ human epiderm& growth factcjs, 
residues 2-49 from [14]. 
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Fig, II%. Comparison of residues 6-43 of tissue-type plasminogen activator with corresponding parts of fibronectin. The 
sequence of human t-PA was taken from IS]; bovine fibronectin from /19]. Tbe standard IUPAC one-letter code for 
amino acid residues was u ed. The blocks enclose residues identical with the corresponding residue in t-PA. 
in all fibronectin fingers, are also conserved in 
plasminogen activator. 
Assuming that the disulphide bond pattern of 
the amino-teeing region of ~ssue~~~ivator is the 
same as in the homologous f~~e~~dorn~~ [19f 
and growth fa~tor~om~~s ff4, 15, 221 the 
covalent structure of the ~~~terrnl~~ 91 residue 
segment of tissue-activator is as depicted in fig.2. 
In view of the homology of the amino-terminal 
region of tissue-type plasminogen activator with 
the fibrin-binding finger-domains of fibronectin, it
-*FINGER-DOMAIN - 
Fig”2, Potential disulphide bond pattern of the amino- 
term&ml region of tissue-type plasminagen activator. 
The proposed isulphide bonds, shown by sorid black 
bars, are based on homology with growth factor- 
dorn~~ of other se&e prcteases and cager-domes of 
flbronectin as shown in Sg_ t. The staztdard IUPAC one- 
letter code for amino acids W&S used, 
seemed possible that this region plays a role in the 
fibrin-affinity of tissue-type plasminogen ac- 
tivator. Ta test this assumption we have subjected 
tissue-type pIasminogen activator to Iimited pro- 
teolysis by ~obil~ed pkmin, since cleavage 
w&h plasmin at Lys-49 or Arg-89, present in the 
inter-domain peptide regiunq wits expected to 
remove the adder-domain {fig* 2). 
As shown in fig.3 proteolysis with plasmin caus- 
ed the conversion of the 65 kDa activator to a - $5 
1 2 
Fig.3, Limited proteolysis of tissue-type p~~~i~o~~~ ac- 
tivator by ~i~~~-Seph~~ 4E. fl) Zymogram of 
melanoma t-PA; (2) ~~rno~~ of a limited plasmic 
digest of mel~oma t-PA, The MS marker proteins used 
were: ph~phor~l~ & 94 km; bovine serum album& 
67 kxla; ov&bumin, 43 kDa; carbonic anhydrase, 30 
kDa. 
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Fig, 4. Adsorption of plasminogen activators to fibrin clot. The retiability of the technique to detect differences in 
~br~n-~~nity of activators is demonstrated by the experiment shown in A. (A) Adsorption of a mixture of tissue-type 
pi~rn~uog~n activator and commercial urokinase to fibrin clot. Zymograms, in: (1) mixture of t-PA and UK; (21 ac- 
tivator species bound to the fibrin clot; (3) activator species not adsorbed to the fibrin clot. (B) Adsorption of 
plasminogen activator species present in the limited plasmic digest of t-PA to fibrin clot. Zymograms, in: (1) Hmited 
plasmic digest of t-PA, (2) activator species bound to the dot; (3) activator species not adsorbed to the fibrin clot. The 
electrophoresis time was doubled to improve separation of t-PA species formed by limited pl~minol~is. The Mr marker 
proteins used were: phosphoryiase b, 94 kDa; bovine serum albumin, 67 kDa; ovalbumin, 43 kDa; carbonic anhydrase, 
30 kDa. 
kDa activator. Similar tow-&& tissue-type activator 
is present in variable amounts as a minor compo- 
nent in preparations obtained from the culture 
fluid of the melanoma cell line (Bowes) used here 
j13, 231. ~pont~~~us appearance of this low-&& 
activator in culture fluids is probably also due to 
limited proteolysis of the 65 kDa activator. The 
-55 kDa tissue-type activator, formed either by 
plasminolysis of the 65 kDa activator, or present as 
a minor component in’ some of the activator 
preparations, was found to lack affinity for fibrin 
clots, whereas the 65 kDa activator was bound to 
fibrin clots (fig.4). This result shows that the - 10 
kDa segment removed by limited proteolysis is 
essential for the fibrin affinity of the activator. 
Since limited proteolysis occurs at 
dorn~~-domain boundaries [24] it seems fikely 
that the - 10 kDa segment removed by limited pro- 
teolysis corresponds to the amino-terminal region 
40 
preceding the kringle domains, in analogy with 
limited plasminolysis of plasminogen [ZS]. 
The homology of fibronectin to tissue-type 
plasminogen activator is apparently restricted to 
the finger-domain. It therefore seems likely that 
gene fusion or exon-reshuffling was the 
mechanism whereby these otherwise unrelated pro- 
teins acquired the same fibrin-binding domain. 
ACKNOWLEDGEMENT 
Thanks are due to Professor D. Cohen (Leuven, 
Belgium) for kindly providing the Bowes human 
melanoma celt. line. 
REFERENCES 
II] WalBn, P. (1977) in: Thrombosis and Wokhtase 
(Paoietti, R. and Sherry, S. eds), pp. 91-102, 
Academic Press, New York. 
Volume 163, number 1 FEBS LETTERS October 1983 
121 
131 
[41 
[51 
WI 
171 
PI 
[91 
WI 
[Ill 
Hoylaerts, M., Rijken, D.C., Lijnen, H.R. and 
Cohen, D. (1982) J. Biol. Chem. 257, 2912-2919. 
Thorsen, S. (1975) Biochim. Biophys. Acta. 393, 
55-65. 
Wiman, B. and Wall&, P. (1977) Thromb. Res. 10, 
213-222. 
Thorsen, S., Glas-Greenwalt, P. and Astrup, T. 
Thromb. Diath. Haemorrh. 28, 65-74. 
Rijken, D.C. and Cohen, D. (1981) J. Biol. Chem. 
256, 7035-7041. 
Wiman, B. and Collen, D. (1978) Nature 272, 
549-550. 
Pennica, D., Holmes, W.E., Kohr, W.J., Harkins, 
R.N., Vehar, G.A., Ward, C.A., Bennett, W.F., 
Yelverton, E., Seeburg, P.H., Heyneker, H.L. 
Goeddel, D.V. and Cohen, D. (1983) Nature 301, 
214-221. 
Giinzler, W.A., Steffens, G.J., Gtting, F., Kim, S- 
M.A., Frankus, E. and Flohe, L. (1982) Hoppe- 
Seyler’s Z. Physiol. Chem. 363, 1151-1165. 
Steffens, G.J., Giinzler, W.A., btting, F. Frankus, 
E. and Flohe, L. (1982) Hoppe Seyler’s Z. Physiol. 
Chem. 363, 1043-1058. 
Magnusson, S., Sottrup-Jensen, L., Petersen, T.E. 
and Claeys, H. (1975) in: Proteases and Biological 
Control (Reich, E. et al. eds) pp. 123-149, Cold 
Spring Harbor Laboratory, New York. 
[12] Sottrup-Jensen, L., Claeys, H., Zaydel, M., 
Petersen, T.E. and Magnusson, S. (1978) in: 
Progress in Chemical Fibrinolysis and 
Thrombolysis (Davidson, J.F. et al. eds) vol. 3, pp. 
191-209, Raven, New York. 
1131 
1141 
1151 
1161 
1171 
WI 
D91 
PO1 
WI 
WI 
1231 
1241 
1251 
Heussen, C. and Dowdle, E.B. (1980) Anal. 
Biochem. 102, 196-202. 
Gregory, H. and Preston, B.M. (1977) Int. J. Pept. 
Prot. Res. 9, 107-118. 
Savage, C.R. jr, Inagami, T. and Cohen, S. (1972) 
J. Biol. Chem. 247, 7612-7621. 
Fernlund, P. and Stenflo, J. (1982) J. Biol. Chem. 
257, 12170-12179. 
Katayama, E., Ericsson, L.H., Enfield, D.L., 
Walsh, K.A., Neurath, H., Davie, E.W. and 
Titani, K. (1979) Proc. Natl. Acad. Sci. USA 76, 
4990-4994. 
Enfield, D.L., Ericsson, L.H., Fujikawa, K., 
Walsh, K.A., Neurath, H., and Titani, K. (1980) 
Biochemistry 19, 659-667. 
Petersen, T.E., Thogersen, H.C., Skorstengaard, 
K., Vibe-Pedersen, K. Sahl, P., Sottrup-Jensen, L. 
and Magnusson, S. (1983) Proc. Natl. Acad. Sci. 
USA 80, 137-141. 
Sekiguchi, K., Fukuda, M. and Hakamori, S.I. 
(1981) J. Biol. Chem. 256, 6452-6462. 
Seidl, M. and Hiirmann, H. (1983) Hoppe-Seyler’s 
Z. Physiol. Chem. 364, 83-92. 
Savage, C.R. jr, Hash, J.H. and Cohen, S. (1973) 
J. Biol. Chem. 248, 7669-7672. 
Wilson, E.L., Becker, M.L.B., Ehoal, E.G. and 
Dowdle, E.B. (1980) Cancer Res. 40, 933-938. 
Neurath, H. (1975) in: Proteases and Biological 
Control (Reich, E. et al. eds) pp. 51-64 Cold 
Spring Harbor Laboratory, New York. 
Walther, P.J., Hill, R.L. and McKee, P.A. (1975) 
J. Biol. Chem. 250, 5926-5933. 
41 
